Lecap Asset Management Ltd. Takes $991,000 Position in The Cooper Companies, Inc. (NASDAQ:COO)

Lecap Asset Management Ltd. acquired a new position in The Cooper Companies, Inc. (NASDAQ:COOFree Report) in the third quarter, HoldingsChannel reports. The fund acquired 8,981 shares of the medical device company’s stock, valued at approximately $991,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in COO. Benjamin F. Edwards & Company Inc. raised its holdings in shares of Cooper Companies by 248.6% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock valued at $25,000 after purchasing an additional 174 shares in the last quarter. Covestor Ltd boosted its position in Cooper Companies by 305.9% during the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after acquiring an additional 208 shares in the last quarter. Innealta Capital LLC bought a new stake in Cooper Companies during the 2nd quarter valued at $25,000. Crewe Advisors LLC increased its holdings in shares of Cooper Companies by 286.4% in the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after acquiring an additional 252 shares during the period. Finally, Clearstead Trust LLC bought a new position in shares of Cooper Companies in the 1st quarter worth $36,000. 24.39% of the stock is currently owned by institutional investors.

Insider Transactions at Cooper Companies

In related news, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the transaction, the chief operating officer now directly owns 44,696 shares in the company, valued at $4,714,534.08. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the transaction, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the sale, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 256,373 shares of company stock worth $27,637,427 over the last 90 days. 2.00% of the stock is currently owned by company insiders.

Cooper Companies Stock Performance

Shares of COO opened at $105.32 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The stock has a 50-day moving average of $104.88 and a two-hundred day moving average of $96.52. The stock has a market cap of $20.97 billion, a P/E ratio of 61.95, a P/E/G ratio of 2.56 and a beta of 0.98. The Cooper Companies, Inc. has a one year low of $75.93 and a one year high of $112.38.

Cooper Companies (NASDAQ:COOGet Free Report) last issued its earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. During the same quarter in the prior year, the firm earned $0.84 earnings per share. Cooper Companies’s revenue for the quarter was up 7.8% on a year-over-year basis. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on COO. Wells Fargo & Company lifted their target price on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Piper Sandler lifted their price objective on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Morgan Stanley increased their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. Robert W. Baird raised their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research note on Thursday, August 29th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 price target (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $115.00.

Read Our Latest Report on Cooper Companies

Cooper Companies Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Further Reading

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COOFree Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.